Equity, International Cooperation, and Global Public Health: Use of the Common but Differentiated Responsibilities Principle in the Fight against COVID-19

During pandemics, in which harm is universal, states find themselves under an obligation to cooperate within a global solidarity framework. However, because they do not have the same set of capabilities, their obligations should be differentiated and based on equity and distributive justice. As an effective tool of States' foreign policy, health diplomacy is being used by developing countries according to different priorities and interests. After a few months of relative calm, COVID-19 still poses a major challenge for African and Middle Eastern economies and societies where the vaccination rates are low across the board with healthcare systems in poor shape. If some Gulf countries can be considered exceptions due to active lockdowns, mobility restrictions, and considerable testing, their engagement abroad to help contain the pandemic, especially in North Africa, shows that, if the spirit of cooperation and justice is well taken care of at the regional level, this is not the case at the international level, where global health cooperation would clearly benefit from the application of a type of differentiated treatment such as the one provided by the Common but Differentiated Responsibilities (CBDR) principle.

COVID-19 Myocarditis: A Case Report, Overview of Diagnosis and Treatment.

Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), emerged in Wuhan, China, and rapidly led to a global pandemic that affected 213 countries, more than 5.8 million cases, and 360,000 deaths worldwide as of May 28, 2020. The United States currently has the highest number of COVID-19 cases in the world and contributes to nearly a third of the global death rate. The prevalence of COVID myocarditis is unclear but generally considered rare, with estimates up to 7% of COVID-related deaths. However, these patients suffered catastrophic worsening disease with respiratory compromise requiring intubation and often death. We report the case of a patient with COVID-19-induced myocarditis who was successfully treated with dexamethasone and review the literature.